AC Immune S.A.

NASDAQ:ACIU

Biotechnology

Healthcare
$2.11 +1.71%

+$0.04 today

Market cap
$214.74M
Beta
1.56
P/E (TTM)
-2.9
EPS (TTM)
-$0.67
52W Low $1.65High $4.00

Volume 0.12M

Average 0.32M

Balance Sheet

Inspect the capital base behind the business.

Assets

$154.43M

FY 2025 · Annual

-33.1% YoY

Liabilities

$109.49M

FY 2025 · Annual

-7.7% YoY

Equity

$44.93M

FY 2025 · Annual

-60.0% YoY

Balance Sheet

CHF
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents82.22M31.59M78.49M36.28M26.83M
Short-term Investments116M91M24.55M129.21M64.69M
Net Receivables975K408K15.05M1.1M681.77K
Inventory00000
Other Current Assets428K392K622K1.1M0
Total Current Assets202.63M128.09M125.15M171.99M96.83M
Property, Plant & Equipment (Net)8.03M7.07M6.88M8.09M6.54M
Goodwill00000
Intangible Assets50.42M50.42M50.42M50.42M50.47M
Long-term Investments00361K0584.66K
Tax Assets00000
Other Non-current Assets363K361K0415K0
Total Non-current Assets58.81M57.84M57.66M58.92M57.59M
Total Assets261.44M185.94M182.81M230.91M154.43M
Account Payables2M929K1.68M2.66M2.07M
Short-term Debt0000852.97K
Tax Payables00000
Deferred Revenue00138K083.8M
Other Current Liabilities717K587K085.06M3.83M
Total Current Liabilities20.03M11.48M13.58M100.84M94.8M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00002.34M
Other Non-current Liabilities7.1M3.21M5.77M13.4M8.66M
Total Non-current Liabilities9.44M5.47M8.6M17.81M14.69M
Total Liabilities29.46M16.95M22.17M118.64M109.49M
Common Stock1.79M1.8M2.09M2.23M2.26M
Retained Earnings(200.94M)(264.02M)(316.2M)(368.24M)(439.52M)
Accumulated OCI010K(51K)(5K)7.01K
Other Stockholders Equity(0)(0)(0)00
Minority Interest00000
Total Equity231.98M168.99M160.64M112.27M44.93M
Total Debt2.91M2.8M3.5M5.43M4.55M
Net Debt(79.31M)(28.79M)(75M)(30.85M)(22.28M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$19.2M
Short-term Investments$55.6M
Receivables$1.5M
Other Current$3.7M
Total Current Assets$80.1M
PP&E (Net)$6.4M
Goodwill$50.4M
Long-term Investments$585.0K
Total Non-current Assets$57.4M
Total Assets$137.4M

Analysis

Selected assets total $137.4M for Latest. The largest visible component is Short-term Investments at $55.6M, about 40.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 4, 2026
3Initial statement of beneficial ownershipOct 9, 2026
3/A3/A filingOct 9, 2026
6-K6-K filingOct 2, 2026
6-K6-K filingSep 23, 2026

How much cash does ACIU have?

AC Immune S.A. (ACIU) reported $26.83M in cash and equivalents in fiscal 2025.

How much debt does ACIU carry?

AC Immune S.A. (ACIU) reported $4.55M of total debt, with net debt of -$22.28M.